Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?
Crossref DOI link: https://doi.org/10.1007/s40618-014-0110-9
Published Online: 2014-06-18
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Williams, Graham R.
Text and Data Mining valid from 2014-06-18
